Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical interferon alfa-2b for diabetic macular edema in diabetic retinopathy
IRCT2016081529370N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of interferon alfa-2b in diabetic retinopathy (DR) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Sep 2016; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on IRCT2016081529370N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016081529370N1.